Back to top
Roberts ST, van der Straten A, Rael CT, Gorbach PM, Palanee-Phillips T, Reddy K, Naidoo K, Dadabhai S, Chinula L, Gaffoor Z, Levy L, Balkus JE, Riddler SA. Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study. AIDS Behav 2022 Sep 13. Epub ahead of print
Mirembe BG, Cabrera MV, van der Straten A, Nakalega R, Cobbing M, Mgodi NM, Palanee-Phillips T, Mayo AJ, Dadabhai S, Mansoor LE, Siva S, Nair G, Chinula L, Akello CA, Nakabiito C, Soto-Torres LE, Baeten JM, Brown ER. Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial. AIDS Behav 2022 Sep 6. Epub ahead of print
Reddy K, Kemigisha D, Chitukuta M, Dadabhai S, Mathebula F, Tenza S, Palanee-Phillips T, Ryan J, Macagna N, Musara P, van der Straten A. ''Ask the way from those who have walked it before"-Grandmothers' roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa. PLoS One 2022 Sep 1;17(9):e0271684. PMCID: PMC9436035
Bauermeister JA, Tingler RC, Ho K, Scheckter R, McClure T, Davis J, Piper J, Friedland BA, Edick S, Song M, Jiao Y, Hendrix CW, Hoesley C. Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037). AIDS Educ Prev 2022 Aug;34(4):257-271.
Jacobson C, Johnson S, Billups T, Mitterer L, Chadza M, Gumede S, Manoyos V, Pareja K, Zemanek J, Jiao Y, Bauermeister J. Overcoming COVID-19 disruptions: Innovations in product provision in a multi-national clinical trial among cisgender men, transgender men and transgender women in five countries. Contemp Clin Trials Commun 2022 Aug;28:100930. PMCID: PMC9167802
Browne EN, Brown ER, Palanee-Phillips T, Reddy K, Naidoo L, Jeenarain N, Nair G, Husnik MJ, Singh D, Scheckter R, Soto-Torres L, Baeten JM, van der Straten A; MTN-020/ASPIRE Study Team. Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. J Acquir Immune Defic Syndr 2022 Aug 1;90(4):418-424. PMCID: PMC9342948
Stoner MCD, Browne EN, Etima J, Musara P, Hartmann M, Shapley-Quinn MK, Kemigisha D, Mutero P, Mgodi NM, Nakabiito C, Bhushan NL, Piper J, van der Straten A, Minnis AM. Couples' decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention. AIDS Behav 2022 Jul 1. doi: 10.1007/s10461-022-03756-9. Epub ahead of print.
Roberts ST, Hawley I, Luecke E, Mensch B, Wagner T, Hoesley C, McClure T, Dominguez Islas CP, Piper JM, Liu AY, van der Straten A. Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial. J Womens Health (Larchmt) 2022 Jul;31(7):1029-1039. PMCID: PMC9299526
Hunidzarira P, Brown ER, Chirenje ZM, Hillier SL, Marrazzo JM, Palanee-Phillips T, Kiweewa FM, Baeten JM; MTN-003/VOICE and MTN-020/ASPIRE Study Teams. Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials. J Infect Dis 2022 Jun 28:jiac269. Epub ahead of print
Austin MN, Meyn LA, Avolia HA, Petrina MA, Cosentino LA, Alphonse C, Chen BA, Bunge K, Noguchi L, Beigi R, Squires K, Hillier SL. Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females. J Infect Dis 2022 Jun 15;225(12):2208-2218. PMCID: PMC9200158
Minnis AM, Etima J, Musara P, Browne EN, Mutero P, Kemigisha D, Mgodi NM, Nakabiito C, Shapley-Quinn MK, Stoner MCD, Hartmann M, Macagna N, Piper J, van der Straten A. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS Behav 2022 Jun 8:1–14. Epub ahead of print. PMCID: PMC9175528
Naidoo K, Montgomery ET, Katz AW, Morgan G, Krishnaveni R, Lydia ST, Sarita N, Leila ME. Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study. AIDS Behav 2022 Jun 7. Epub ahead of print
Reddy K, Mathebula F, Katz A, Luecke E, Tenza S, Palanee-Phillips T, Garcia M, Mansoor LE, Naidoo S, Morar N, Chitukuta M, Tsidya M, Montgomery ET; MTN-032 Study team. Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2022 Jun;26(6):1923-1932. PMCID: PMC9050873
Katz AWK, Balán IC, Reddy K, Etima J, Weber K, Tauya T, Atujuna M, Scheckter R, Ngure K, Soto-Torres L, Mgodi N, Palanee-Phillips T, Baeten JM, van der Straten A. Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring. AIDS Behav 2022 May 10. Epub ahead of print
Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET; MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS Behav 2022 May;26(5):1597-1606. PMCID: PMC9007827
Bauermeister JA, Tingler RC, Dominguez C, Dunne EF, Hoesley C, Ho K, Johnson S, Lucas J, Macagna N, Brown E, Gundacker H, Peda M, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Ayudhya RPKN, Marzinke MA, Piper J, Devlin B, Nuttall J, McGowan I, Hendrix CW, Cranston RD; MTN 026 team. Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS Behav 2022 May;26(5):1333-1346. PMCID: PMC9024063
Hawley I, Song M, Scheckter R, McClure T, Piper J, Chen B, Hoesley C, Liu A, van der Straten A. Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials. AIDS Res Hum Retroviruses 2022 Apr;38(4):313-326. PMCID: PMC9048173
McGowan IM, Kunjara Na Ayudhya RP, Brand RM, Marzinke MA, Hendrix CW, Johnson S, Piper J, Holtz TH, Curlin ME, Chitwarakorn A, Raengsakulrach B, Doncel G, Schwartz Icloud Com J, Rooney JF, Cranston RD. An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate. AIDS Res Hum Retroviruses. 2022 Apr;38(4):279-287. PMCID: PMC9048169
Cranston RD, Brown E, Bauermeister J, Dunne EF, Hoesley C, Ho K, Johnson S, Lucas J, Dominguez-Islas C, Gundacker H, Peda M, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Kunjara Na Ayudhya RP, Brand RM, Wang L, Marzinke MA, Piper J, Devlin B, Nuttall J, McGowan I, Hendrix CW. A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS Res Hum Retroviruses 2022 Apr;38(4):257-268. PMCID: PMC9048178
Shapley-Quinn MK, Laborde N, Luecke E, Hoesley C, Salata RA, Johnson S, Nel A, Soto-Torres L, Chen BA, van der Straten A. Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women. AIDS Patient Care STDS 2022 Mar;36(3):97-105. PMCID: PMC8971982
Ryan JH, Young A, Musara P, Reddy K, Macagna N, Guma V, Seyama L, Piper J, van der Straten A; MTN- 041/MAMMA Study Team. Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery: A Qualitative Study in Malawi, South Africa, Uganda, and Zimbabwe. AIDS Behav 2022 Mar;26(3):996-1005. PMCID: PMC8840901
Balán IC, Lentz C, Giguere R, Dolezal C, Kajura-Manyindo C, Kutner BA, Zalwango A, Makoni R, Madlala B, Makala Y, Khanyile N, Kadyamusuma M, Kachenjera L, Ndhlovu-Forde Z, Tuswa-Haynes N. Inconsistent Counselor Fidelity in Delivering an Evidence-Based Adherence Intervention During a PrEP Trial. AIDS Behav 2022 Mar;26(3):698-708. PMCID: PMC8840968
Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. AIDS Behav 2022 Mar;26(3):752-763. PMCID: PMC8840958
Stoner MCD, Browne EN, Gundacker HM, Hawley I, Chen BA, Hoesley C, Scheckter R, Piper J, Singh D, Song M, Liu A, van der Straten A. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS One 2022 Feb 22;17(2):e0263664. PMCID: PMC8863232
Ridgeway K, Montgomery ET, Smith K, Torjesen K, Straten AV, Achilles SL, Griffin JB. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception 2022 Feb;106:16-33. PMCID: PMC9128798
Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, Taljaard M, Panchia R, Baeten JM, Balkus JE, Hladik F, Celum CL, Barnabas RV. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization. AIDS 2022 Feb 1;36(2):257-265. PMCID: PMC8702475
Tolley EE, Martinez A, Zissette S, Palanee-Phillips T, Mathebula F, Tenza S, Hartmann M, Montgomery ET. Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study. PLoS One 2021 Dec 31;16(12):e0261526. PMCID: PMC8719706
Katz AWK, Mansoor LE, Tsidya M, Mathebula F, Singh D, Siva S, Akello C, Chitowa TH, Garcia M, Soto-Torres L, Montgomery ET. Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2021 Dec;25(12):3955-3966. PMCID: PMC8631950
Stoner MCD, Brown ER, Palanee-Phillips T, Mansoor LE, Tembo T, Nair G, Akello C, Seyama L, Jeenarain N, Naidoo L, Mgodi N, Hunidzarira P, Chitukuta M, van der Straten A; MTN-020 ASPIRE and M-025 HOPE study teams. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence. AIDS Behav 2021 Dec;25(12):4169-4179. PMCID: PMC8563504
Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A; MTN-025/HOPE Study Team. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. AIDS Behav 2021 Dec;25(12):3847-3857. PMCID: PMC8602444
Lokken EM, Mathur A, BungeKE, Fairlie L, Makanani B, Beigi R, Noguchi L, Balkus JE. Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy. Front Reprod Health. 2021;3:672446. PMCID: PMC8856667
Sekhon M, van der Straten A; MTN-041/MAMMA Study Team. Pregnant and breastfeeding women's prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability. PLoS One 2021 Nov 16;16(11):e0259779. PMCID: PMC8594804
Jacobson C, Moodley J, Bhoola A, Sakwa R, Moodley J, Sukdao J, Hurbans N, Maharaj B, Naidoo A, Maclachlan M, Chareka G, Hlahla K, Chadza M; MTN-020/ASPIRE Study Team. Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial. Contemp Clin Trials Commun 2021 Nov 12;24:100859. PMCID: PMC8605196
Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, Kemigisha D, Musara P, Mansoor LE, Singh N, Woeber K, Morar NS, Jeenarain N, Gaffoor Z, Gondwe DK, Makala Y, Fleurs L, Reddy K, Palanee-Phillips T, Baeten JM, van der Straten A, Soto-Torres L, Torjesen K. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study. BMC Public Health. 2021 Nov 8;21(1):2041. PMCID: PMC8576984
Parikh UM, Penrose KJ, Heaps AL, Halvas EK, Goetz BJ, Gordon KC, Hardesty R, Sethi R, Schwarzmann W, Szydlo DW, Husnik MJ, Chandran U, Palanee-Phillips T, Baeten JM, Mellors JW; MTN-020 Study Team. HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. J Int AIDS Soc 2021 Nov;24(11):e25833. PMCID: PMC8583424
Bauermeister JA, Tingler RC, Johnson S, Macagna N, Lucas J, Dominguez-Islas C, Szydlo D, Ngo J, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Kunjara Na Ayudhya RP, Piper J, Devlin B, Hendrix CW, Ho K; MTN-033 Protocol Team. Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study). AIDS Educ Prev 2021 Oct;33(5):361-376. PMCID: PMC8637489
Nakalega R, Akello C, Gati B, Nakabiito C, Nolan M, Kamira B, Etima J, Nakyanzi T, Kemigisha D, Nanziri SC, Nanyonga S, Nambusi MJ, Mulumba E, Biira F, Nabunya HK, Akasiima SA, Nansimbe J, Maena J, Babirye JA, Ngure K, Mujugira A. Ethical considerations for involving adolescents in biomedical HIV prevention research. BMC Med Ethics 2021 Sep 23;22(1):127. PMCID: PMC8461968
Husnik MJ, Brown ER, Dadabhai SS, Gaffoor Z, Jeenarain N, Kiweewa FM, Livant E, Mansoor LE, Mirembe BG, Palanee-Phillips T, Singh D, Siva S, Soto-Torres L, van der Straten A, Baeten JM; M. T. N.-020/ASPIRE Study Team. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS Behav 2021 Sep;25(9):2801-2814. PMCID:PMC8577988
Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, Singh D, Bunge KE, Naidoo L, Makanani B, Jeenarain N, Reynolds D, Hillier SL, Brown ER, Baeten JM, Balkus JE, MTN-020/ASPIRE study team. Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis 2021 Aug 2;73(3):513-520. PMCID: PMC8326546.
Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, Seyama L, Woeber K, Harkoo I, Reddy K, Tembo T, Mutero P, Tauya T, Chitukuta M, Gati Mirembe B, Soto-Torres L, Brown ER, Baeten JM, van der Straten A; MTN-020/ASPIRE study team. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav 2021 Aug;25(8):2430-2440. PMCID: PMC8222015
Noguchi LM, Marrazzo JM, Richardson B, Hillier SL, Balkus JE, Palanee-Phillips T, Nair G, Panchia R, Piper J, Gomez K, Ramjee G, Chirenje ZM. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa. Front Reprod Health 2021 Jul;3:668685. PMCID: PMC9165437
Baker Z, Javanbacht M, Moore J, Brosnan H, Squires K, Bunge K, Zimet G, Mensch B, Soto-Torres L, Kapogiannis B, Levy L, Hoesley C, Reirden D, Gaur A, Mayer K, Futterman D, Gorbach P. A qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls. J Acquir Immune Defic Syndr 2021 Jul 1;87(3):944-950. PMCID: PMC8192420
Liu AY, Dominguez Islas C, Gundacker H, Neradilek B, Hoesley C, van der Straten A, Hendrix CW, Beamer M, Jacobson CE, McClure T, Harrell T, Bunge K, Devlin B, Nuttall J, Spence P, Steytler J, Piper JM, Marzinke MA; MTN-036/IPM 047 Protocol Team for the Microbicide Trials Network. Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. J Int AIDS Soc 2021 Jun;24(6):e25747. PMCID: PMC8196716
Rael CT, Roberts S, Ibitoye M, Gorbach PM, Palanee-Phillips T, Harkoo I, Mbilizi Y, Panchia R, Siva S, Tembo T, Agwau Akello C, Balkus J, Riddler S, Carballo-Diéguez A. Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan Africa. Int J STD AIDS 2021 Jun;32(7):620-628. PMCID: PMC8594455
Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav 2021 Jun;25(6):1890-1900. PMCID: PMC8516082
Naidoo S, Duby Z, Hartmann M, Musara P, Etima J, Woeber K, Mensch BS, van der Straten A, Montgomery ET. Application of a Body Map Tool to Enhance Discussion of Sexual Behavior in Women in South Africa, Uganda, and Zimbabwe. Field methods 2021 May 1;33(2):143-158. PMCID: PMC8356637
Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E; MTN-020/ASPIRE Study Team. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa. BMC Womens Health 2021 Apr 23;21(1):175. PMCID: PMC8067655
Young A, Ryan J, Reddy K, Palanee-Phillips T, Chitukuta M, Mwenda W, Kemigisha D, Musara P, van der Straten A; MTN-041/MAMMA Study Team. Religious leaders' role in pregnant and breastfeeding women's decision making and willingness to use biomedical HIV prevention strategies: a multi-country analysis. Cult Health Sex 2021 Apr 2:1-16. Epub ahead of print. PMCID: PMC8627258
Flax VL, Hawley I, Ryan J, Chitukuta M, Mathebula F, Nakalega R, Seyama L, Taulo F, van der Straten A; MTN-041/MAMMA Study Team. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa. Matern Child Nutr 2021 Apr;17(2):e13120. PMCID: PMC7988874
Naidoo K, Mansoor LE, Katz AW, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET. Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial. J Acquir Immune Defic Syndr 2021 Apr 1;86(4):e90-e96. PMCID: PMC7902420